Two Cycles Versus Three Cyclle of CCRT for Low Risk Locoregionally Advanced Nasopharyngeal Carcinoma
Status:
Unknown status
Trial end date:
2021-07-01
Target enrollment:
Participant gender:
Summary
This is a Phase II trial to study the effectiveness of two cycles versus three cycles of
Concurrent Chemoradiotherapy in treating patients with Low Risk Locoregionally Advanced
Nasopharyngeal Carcinoma based on pretreatment plasma EBV DNA.